In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Doxycycline hyclate (internal use) Drug Master File in Korea (Doxycycline hyclate (internal use) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Doxycycline hyclate (internal use). The MFDS reviews the Doxycycline hyclate (internal use) KDMF as part of the drug registration process and uses the information provided in the Doxycycline hyclate (internal use) KDMF to evaluate the safety and efficacy of the drug.
After submitting a Doxycycline hyclate (internal use) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Doxycycline hyclate (internal use) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Doxycycline hyclate (internal use) suppliers with KDMF on PharmaCompass.